By Turna Ray
This article was originally posted on Oct. 30.
Even Google-backed 23andMe isn't shielded from the economic crisis.
The Mountain View, Calif.-based direct-to-consumer genomics firm has had a round of layoffs that it said were necessary to remain in business in a difficult economic climate. With competitor Decode Genetics also cutting back, Navigenics proceeding cautiously, and TruGenetics in a holding pattern as it seeks funding, times are tough for DTC consumer genomics firms.